Welcome to the ADAURA Study website

If you have been diagnosed with early-stage lung cancer, you may be interested to learn more about the ADAURA Study

ADAURA is a large, global clinical research study that will assess whether a new investigational drug is more effective than matching placebo at prolonging disease-free survival in patients with non-small cell lung cancer (NSCLC), who have had their tumor surgically removed*

If you are at least 18 years of age (20 years if in Japan or Taiwan) and have been diagnosed with early-stage NSCLC, we invite you to find out more about the ADAURA Study. Please click on the appropriate link below to navigate to the study website for your country

*Other requirements (which will be assessed by the study personnel) will also need to be met before you can join the study.